stock
gist
Home
Top Movers
Companies
Concepts
Filings
Toggle search
SCHEDULE 13G - Aligos Therapeutics, Inc. | StockGist | StockGist
Companies
ALGS
SCHEDULE 13G
stock
gist
Home
Top Movers
Companies
Concepts
Filings
Toggle search
Home
Filings
ALGS
SCHEDULE 13G
SCHEDULE 13G
Beneficial Ownership
Aligos Therapeutics, Inc.
Filed Aug 13, 2025
Accepted Aug 12, 2025, 8:00 PM ET
ALGS
CIK 0001799448
View on SEC.gov
Company Profile
0001214659-25-011951
Beneficial Ownership Report
Passive Investment
Shares Owned
355,937
Reporting Person
Aligos Therapeutics, Inc.
Person Type
IA
CUSIP: 01626L204
Amendment History
4 filings
SCHEDULE 13G
Original
Viewing
Aug 13, 2025
0001214659-25-011951
SCHEDULE 13G/A
Amendment 1
Aug 12, 2025
0000902664-25-003496
SCHEDULE 13G/A
Amendment 2
Aug 14, 2025
0000902664-25-003590
SCHEDULE 13G/A
Amendment 3
Latest
Feb 17, 2026
0000902664-26-001065